1 option
CADTH Canadian Drug Expert Committee recommendation : Ocrelizumab (Ocrevus-Hoffmann-La Roche Limited) : indication : management of adult patients with early primary progressive multiple sclerosis (PPMS) as defined by disease duration and level of disability, in conjunction with imaging features characteristic of inflammatory activity / CADTH Canadian Drug Expert Committee.
- Format:
- Book
- Author/Creator:
- CADTH Canadian Drug Expert Committee, author.
- Series:
- Common drug review clinical review report.
- Common drug review clinical review report
- Language:
- English
- Subjects (All):
- Drugs--Cost effectiveness.
- Drugs.
- Physical Description:
- 1 online resource.
- Edition:
- First edition.
- Place of Publication:
- Ottawa, ON : CADTH, 2018.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.